South Korea Injectable Drug Delivery Market Insight
Published: 18 July 2026 | Report Format: Electronic (PDF) | Author: Govind and Krishna
The market for injectable drug delivery in South Korea is predicted to increase at compound annual growth rate of roughly 7.65% due to rise in chronic illnesses and biologic treatments.
South Korea Injectable Drug Delivery Market Insights Forecasts to 2035
- The South Korea Injectable Drug Delivery Market Size Was Estimated USD 2.54 Billion in 2025
- The Market Size is Expected to Grow at a CAGR of around 7.65% from 2025 to 2035
- The South Korea Injectable Drug Delivery Market Size is Expected to rise around USD 5.31 Billion by 2035
Notable Insights for the South Korea Injectable Drug Delivery Market
- According to product type segmentation, the drug delivery market is dominated by injectable devices, such as wearable and auto-injectors, while sophisticated formulations, such as long-acting injectables, are becoming increasingly popular.
- According to application segmentation, autoimmune disorders and infectious diseases exhibit consistent growth, while oncology and diabetes lead the market due to high biologic utilization.
- Through regulatory simplification, the South Korean government encourages the adoption of biosimilars, homegrown biosimilars receive worldwide first approvals but have poor domestic penetration rates.
- Injectable platforms accounted for 36.78% of the drug delivery market in South Korea, which grew at an 8.47% CAGR to reach USD 5.08 billion in 2025.
Download the eBook (ToC)
What Makes Decisions Advisors Research Unique?
- AI-Driven Drug Delivery & Biopharmaceutical Intelligence
Decisions Advisors offers innovative AI-powered research on injectable drug delivery systems, extended-release drugs, and biological products platform for the South Korea Injectable Drug Delivery Market. Opportunities for new delivery technology, extended-release injections, and self-delivery devices in South Korea are revealed through this research.
- Robust Research Methodology with Accurate Forecasting Models
This study utilizes direct interviews with drug delivery firms, pharmaceutical producers, and medical practitioners together with secondary research from governmental health policy papers, industry reports, and clinical trial registers. In case of South Korea Injectable Drug Delivery Market, this ensures accuracy of market figures, CAGR prediction, investment opportunities, and technology adoption.
- Comprehensive Competitive and Ecosystem Analysis
In the research, the top suppliers in injectable devices, drug delivery systems and formulations technologies are evaluated. This market research provides detailed analysis on how competitive positioning, innovations in long-acting injectable technologies, partnerships, and regulations are influencing the South Korea Injectable Drug Delivery Market.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the South Korea injectable drug delivery market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in South Korea Injectable Drug Delivery Market
- Samsung Bioepis
- Daewoong Pharmaceutical
- Yuhan Corporation
- Dongkook Pharmaceutical
- GC Biopharma
- Inventage Lab
- G2GBIO
- Celltrion
- Samik Pharm
- TionLab Therapeutics
Recent Developments:
- In April 2025, an improved long-acting injectable formulation was introduced with the goal of enhancing patient adherence. The company also worked with domestic hospitals to boost clinical use and commercialization.
- In March 2025, developed novel injectable treatments using cutting-edge delivery technologies in collaboration with a biotechnology company, improving treatment accuracy, production efficiency, and patient convenience.
Market Segmentation:
South Korea Injectable Drug Delivery Market, By Product Type
- Devices
- Formulations
South Korea Injectable Drug Delivery Market, By Site of Administration
- Intravenous
- Intramuscular
- Subcutaneous
South Korea Injectable Drug Delivery Market, By Application
- Oncology
- Diabetes
- Autoimmune Diseases
- Infectious Diseases
- Hormonal Disorders
Expert Views:
The South Korea injectable drug delivery market is going to see a lot of growth. This is because more people are getting diseases. Also, doctors are using biologics. Biosimilars more often. The South Korea Injectable Drug Delivery Market is also growing because of better injectable drug delivery systems. People need to be able to give themselves shots at home. The South Korea Injectable Drug Delivery Market for self-injecting devices is growing.
Author: Govind and Krishna By Decisions Advisors and Consulting